PubRank

Susanne Osanto

Author PubWeight™ 38.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005 6.16
2 Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int 2012 3.41
3 Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2010 1.80
4 The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 2011 1.61
5 Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012 1.50
6 Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. Eur J Cancer 2011 1.45
7 Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol 2005 1.30
8 The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res 2010 1.28
9 Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007 1.14
10 Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy. Clin Cancer Res 2006 1.06
11 Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study. Eur J Cancer 2012 1.04
12 Current vaccination strategies for prostate cancer. Eur Urol 2011 1.01
13 Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013 1.00
14 Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2010 0.93
15 Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha. Cancer Immunol Immunother 2011 0.92
16 CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame. J Immunol 2003 0.87
17 Emerging novel therapies for advanced prostate cancer. Ther Adv Urol 2012 0.87
18 Deep-sequencing analysis reveals that the miR-199a2/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in Sézary syndrome. J Invest Dermatol 2012 0.85
19 Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates. Cancer Immunol Immunother 2004 0.84
20 Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 2013 0.83
21 Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica 2012 0.83
22 Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy. Acta Oncol 2013 0.82
23 Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors. Exp Hematol 2003 0.80
24 Advanced seminoma and nonseminoma: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 2011 0.80
25 Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies. Cancer Treat Rev 2012 0.78
26 Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma. J Gene Med 2003 0.78
27 Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma. Cancer Immunol Immunother 2006 0.78
28 Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients. Br J Clin Pharmacol 2014 0.77
29 Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber. Cancer Gene Ther 2004 0.77
30 False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature. Oncologist 2008 0.76
31 A critical need for national guidelines. Onkologie 2010 0.75
32 Reply: Seminoma stage 1: Patterns of care in Europe. BJU Int 2013 0.75
33 Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes. J Immunol 2004 0.75
34 Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thromb Res 2012 0.75
35 Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma. Blood Coagul Fibrinolysis 2012 0.75
36 Hurdles in modern trial management: as overbureaucracy and commercialization of clinical trials suffocate independent academic research, it's time for a change. Eur Urol 2009 0.75